ATE55780T1 - Hybridomazellinie und ihr monoklonaler antikoerper gegen erythropoietin. - Google Patents

Hybridomazellinie und ihr monoklonaler antikoerper gegen erythropoietin.

Info

Publication number
ATE55780T1
ATE55780T1 AT84300693T AT84300693T ATE55780T1 AT E55780 T1 ATE55780 T1 AT E55780T1 AT 84300693 T AT84300693 T AT 84300693T AT 84300693 T AT84300693 T AT 84300693T AT E55780 T1 ATE55780 T1 AT E55780T1
Authority
AT
Austria
Prior art keywords
erythropoieten
cellline
hybridoma
monoclonal antibodies
antibodies against
Prior art date
Application number
AT84300693T
Other languages
English (en)
Inventor
Joan Egrie
Original Assignee
Kirin Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23841115&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE55780(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kirin Amgen Inc filed Critical Kirin Amgen Inc
Application granted granted Critical
Publication of ATE55780T1 publication Critical patent/ATE55780T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/746—Erythropoetin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT84300693T 1983-02-04 1984-02-03 Hybridomazellinie und ihr monoklonaler antikoerper gegen erythropoietin. ATE55780T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/463,724 US4558006A (en) 1983-02-04 1983-02-04 A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin
EP84300693A EP0116446B1 (de) 1983-02-04 1984-02-03 Hybridomazellinie und ihr monoklonaler Antikörper gegen Erythropoietin

Publications (1)

Publication Number Publication Date
ATE55780T1 true ATE55780T1 (de) 1990-09-15

Family

ID=23841115

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84300693T ATE55780T1 (de) 1983-02-04 1984-02-03 Hybridomazellinie und ihr monoklonaler antikoerper gegen erythropoietin.

Country Status (8)

Country Link
US (1) US4558006A (de)
EP (1) EP0116446B1 (de)
JP (1) JPS60500558A (de)
AT (1) ATE55780T1 (de)
CA (1) CA1210345A (de)
DE (1) DE3483008D1 (de)
IL (1) IL71001A (de)
WO (1) WO1984003152A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686480B2 (ja) * 1983-02-21 1994-11-02 雪印乳業株式会社 エリスロポエチン製造用モノクローナル抗体
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
CN1062907C (zh) * 1984-11-30 2001-03-07 柯瑞英-艾格公司 生产抗体物质的方法
US4677195A (en) * 1985-01-11 1987-06-30 Genetics Institute, Inc. Method for the purification of erythropoietin and erythropoietin compositions
NZ218336A (en) * 1985-12-09 1991-08-27 Kirin Amgen Inc Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf)
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
JPH02265498A (ja) * 1988-11-16 1990-10-30 Shionogi & Co Ltd ｒｅｇタンパク質を認識するモノクローナル抗体
US6932968B1 (en) 1989-07-26 2005-08-23 Dade Behring Marburg Gmbh Erythropoietin (EPO) peptides and antibodies directed against these
DE3924746A1 (de) * 1989-07-26 1991-01-31 Behringwerke Ag Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
SE9004047L (sv) * 1990-12-19 1992-06-20 Francisco Batista Metod foer immobilisering av tiolfoereningar via aktivering av polymerer, aktiverade polymerer, och produkter erhaallna med metoden
US5625035A (en) * 1992-06-05 1997-04-29 The Regents, University Of California Erythropoietin binding protein from mammalian serum
US6048704A (en) 1996-03-07 2000-04-11 The Trustees Of Columbia University Purified and recombinant antigenic protein associated with abdominal aortic aneurysm (AAA) disease, and diagnostic and therapeutic use thereof
US6696411B1 (en) * 1998-04-22 2004-02-24 Cornell Research Foundation, Inc. Canine erythropoietin gene and recombinant protein
USRE40911E1 (en) 1998-04-22 2009-09-08 Cornell Research Foundation, Inc. Canine erythropoietin gene and recombinant protein
RU2151184C1 (ru) * 1998-12-09 2000-06-20 Общество с ограниченной ответственностью "Протеиновый контур" Штаммы культивируемых гибридом мышей - продуценты моноклональных антител к человеческому эритропоэтину и антитела, ими продуцируемые
RU2145610C1 (ru) * 1998-12-09 2000-02-20 Общество с ограниченной ответственностью "Протеиновый контур" Способ очистки рекомбинантного эритропоэтина человека
DK2298301T3 (en) 2001-12-06 2018-10-01 Fibrogen Inc MEDICINALS FOR TREATMENT OF ANEMIA ASSOCIATED WITH Kidney Disease
KR100473172B1 (ko) * 2002-11-27 2005-03-10 씨제이 주식회사 인간 에리스로포이에틴과 변형 에리스로포이에틴을 모두인식하는 모노클로날 항체 및 그를 생산하는 융합세포주
CA2521273A1 (en) * 2003-04-02 2004-10-21 Epimmune Inc. Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production
EP1736481A1 (de) * 2005-05-13 2006-12-27 Charite Universitätsmedizin-Berlin Erythropoietinvarianten
AU2015249144B2 (en) * 2005-08-05 2017-06-29 Araim Pharmaceuticals, Inc. Tissue protective peptides and uses thereof
SI2540309T1 (en) 2005-08-05 2018-04-30 Araim Pharmaceuticals, Inc. Tissue protective peptides and their uses
WO2007060213A2 (en) * 2005-11-24 2007-05-31 Laboratoires Serono S.A. Erythropoietin polypeptides and uses thereof
KR20200075044A (ko) 2008-01-22 2020-06-25 아라임 파마슈티칼즈, 인크. 조직 손상 관련 질환 및 장애를 예방 및 치료하기 위한 조직 보호 펩티드 및 펩티드 유사체
RU2451071C1 (ru) * 2010-12-10 2012-05-20 Российская Федерация, от имени которой выступает Министерство образования и науки Российской Федерации (Минобрнауки России) Штамм гибридных культивируемых клеток животных mus musculus - продуцент моноклональных антител к рекомбинантному эритропоэтину человека (варианты)
WO2012106472A1 (en) 2011-02-02 2012-08-09 Fibrogen, Inc. Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase
AU2013290438C1 (en) 2012-07-16 2019-01-03 Kyntra Bio, Inc. Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
EP3219706A1 (de) 2012-07-16 2017-09-20 Fibrogen, Inc. Verfahren zur herstellung von isochinolinverbindungen
RU2717038C1 (ru) * 2019-01-29 2020-03-17 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства Штамм клеток cho-se-9/4 - продуцент химерного антитела против эритропоэтина человека и химерное антитело, продуцируемое данным штаммом

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US465624A (en) * 1891-12-22 Hydrocarbon-burner
US3033753A (en) * 1959-08-31 1962-05-08 Wilfrid F White Erythropoietic factor purification
US4423147A (en) * 1980-04-11 1983-12-27 Secher David S Monoclonal antibody to interferon-α
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
IT1185503B (it) * 1984-01-11 1987-11-12 Univ New York Cloni di odna di eritropietina umana

Also Published As

Publication number Publication date
IL71001A (en) 1990-06-10
US4558006A (en) 1985-12-10
CA1210345A (en) 1986-08-26
EP0116446A3 (en) 1986-05-14
WO1984003152A1 (en) 1984-08-16
JPS60500558A (ja) 1985-04-25
EP0116446B1 (de) 1990-08-22
EP0116446A2 (de) 1984-08-22
DE3483008D1 (de) 1990-09-27

Similar Documents

Publication Publication Date Title
ATE55780T1 (de) Hybridomazellinie und ihr monoklonaler antikoerper gegen erythropoietin.
DE3278203D1 (en) Monoclonal antibodies specific for the human transferrin receptor glycoprotein
EP0176355A2 (de) Immunologisches Verfahren unabhängig von Antigenen
Brenner et al. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation
Cordon-Cardo et al. Immunoanatomic distribution of cytostructural and tissue-associated antigens in the human urinary tract
CA2180425A1 (en) Purified primate ctla-8 antigens and related reagents
Shulman et al. Mutations affecting the structure and function of immunoglobulin M
DE3785038D1 (de) Monoklonale antikoerper gegen nicht reduzierte, nicht enzymatisch glykolysierte proteine.
ATE71141T1 (de) Diagnosesystem zum nachweis von cytomegalovirus.
US4533496A (en) Method of isolating monoclonal antibodies from hybridoma cultures
David et al. The hybridoma-an immunochemical laser.
ATE62273T1 (de) Monoklonaler antikoerper und verfahren zur quantitativen bestimmung von immunoglobulinen mittels dieses antikoerpers.
EP0522169B1 (de) Gegen menschliches stromelysin gerichteter monoklonaler antikörper und diagnose rheumatischer arthritis mittels enzym-immuntest
ATE87941T1 (de) Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens.
WO1991019001A1 (en) Immunodiagnostic assay for rheumatoid arthritis
EP0401370B1 (de) Enzymimmuntest für menschliches typiv-collagen gemäss dem sandwichverfahren
US4863850A (en) Method for diagnosis of rheumatoid arthritis
US4610960A (en) Monoclonal antibody to thrombospondin and method for assaying for and isolating thrombospondin
DE3685145D1 (de) Monoklonale antikoerper gegen atriale, natriurethische peptide.
US5094942A (en) Detection of antibodies binding carboxypeptidase in serum of cancer patients
GB2199833A (en) Preparation of monoclonal antibodies
ATE81909T1 (de) Hybridomen-tumor-zellinien und deren monoklonale antikoerper gegen thaumatin.
Telakowski-Hopkins et al. Isolation and characterization of monoclonal antibodies against rat liver epoxide hydrolase
US5985587A (en) Polypeptide-induced monoclonal receptors to protein ligands
Bütikofer et al. ‘Crossed immunoblotting’: Identification of proteins after crossed immunoelectrophoresis and electrotransfer to nitrocellulose membranes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time